-
1
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
-
Early Breast Cancer Trialists' Collaborative Group
-
Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365 (2005) 1687-1717
-
(2005)
Lancet
, vol.365
, pp. 1687-1717
-
-
-
2
-
-
34249001858
-
Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer
-
Anderson W., Chen B., Jatoi A., and Rosenberg P. Effects of estrogen receptor expression and histopathology on annual hazard rates of death from breast cancer. Breast Cancer Res Treat 100 (2006) 121-126
-
(2006)
Breast Cancer Res Treat
, vol.100
, pp. 121-126
-
-
Anderson, W.1
Chen, B.2
Jatoi, A.3
Rosenberg, P.4
-
3
-
-
0018191112
-
The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer
-
Lippman M., Allegra J., Thompson E., et al. The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer. N Engl J Med 298 (1978) 1223-1228
-
(1978)
N Engl J Med
, vol.298
, pp. 1223-1228
-
-
Lippman, M.1
Allegra, J.2
Thompson, E.3
-
4
-
-
0019141362
-
Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer
-
Rubens R., and Hayward J. Estrogen receptors and response to endocrine therapy and cytotoxic chemotherapy in advanced breast cancer. Cancer 46 (1980) 2922-2924
-
(1980)
Cancer
, vol.46
, pp. 2922-2924
-
-
Rubens, R.1
Hayward, J.2
-
5
-
-
0019171535
-
Estrogen receptor status and response to chemotherapy in advanced breast cancer: the Tufts-Shattuck-Pondville experience
-
Rosenbaum C., Marsland T., Stolbach L., et al. Estrogen receptor status and response to chemotherapy in advanced breast cancer: the Tufts-Shattuck-Pondville experience. Cancer 46 suppl 12 (1980) 2919-2921
-
(1980)
Cancer
, vol.46
, Issue.SUPPL. 12
, pp. 2919-2921
-
-
Rosenbaum, C.1
Marsland, T.2
Stolbach, L.3
-
6
-
-
0019201572
-
Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer
-
Young P., Ehrlich C., Einhorn L., et al. Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer. Cancer 46 (1980) 2961-2963
-
(1980)
Cancer
, vol.46
, pp. 2961-2963
-
-
Young, P.1
Ehrlich, C.2
Einhorn, L.3
-
7
-
-
0019781955
-
Correlation of estrogen receptors and response to chemotherapy of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in advanced breast cancer
-
Chang J., and Wergowske G. Correlation of estrogen receptors and response to chemotherapy of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in advanced breast cancer. Cancer 48 (1981) 2503-2506
-
(1981)
Cancer
, vol.48
, pp. 2503-2506
-
-
Chang, J.1
Wergowske, G.2
-
8
-
-
0019209829
-
Estrogen receptor status and response to chemotherapy in advanced breast cancer
-
Kiang D., Frenning D., Gay J., et al. Estrogen receptor status and response to chemotherapy in advanced breast cancer. Cancer 46 suppl 12 (1980) 2814-2817
-
(1980)
Cancer
, vol.46
, Issue.SUPPL. 12
, pp. 2814-2817
-
-
Kiang, D.1
Frenning, D.2
Gay, J.3
-
9
-
-
0018251080
-
Estrogen receptor and responses to chemotherapy and hormonal therapy in advanced breast cancer
-
Kiang D., Frenning D., Goldman A., et al. Estrogen receptor and responses to chemotherapy and hormonal therapy in advanced breast cancer. N Engl J Med 299 (1978) 1330-1334
-
(1978)
N Engl J Med
, vol.299
, pp. 1330-1334
-
-
Kiang, D.1
Frenning, D.2
Goldman, A.3
-
10
-
-
0026557343
-
Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women
-
Early Breast Cancer Trialists' Collaborative Group 71-85.
-
Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 women. Lancet 339 (1992) 1-15 71-85.
-
(1992)
Lancet
, vol.339
, pp. 1-15
-
-
-
11
-
-
0032547564
-
Polychemotherapy for early breast cancer: an overview of the randomised trials
-
Early Breast Cancer Trialists' Collaborative Group
-
Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet 352 (1998) 930-942
-
(1998)
Lancet
, vol.352
, pp. 930-942
-
-
-
12
-
-
0024393056
-
Antagonism of chemotherapy-induced cytoxicity for human breast cancer cells by anti-estrogens
-
Osborne C., Kitten L., and Artega C. Antagonism of chemotherapy-induced cytoxicity for human breast cancer cells by anti-estrogens. J Clin Oncol 7 (1989) 710-717
-
(1989)
J Clin Oncol
, vol.7
, pp. 710-717
-
-
Osborne, C.1
Kitten, L.2
Artega, C.3
-
13
-
-
0030841871
-
Overview of randomized trials of perioperative polychemotherapy trials in women with early-stage breast cancer
-
Clahsen P., van de Velde C., Goldhirsch A., et al. Overview of randomized trials of perioperative polychemotherapy trials in women with early-stage breast cancer. J Clin Oncol 15 (1997) 2526-2535
-
(1997)
J Clin Oncol
, vol.15
, pp. 2526-2535
-
-
Clahsen, P.1
van de Velde, C.2
Goldhirsch, A.3
-
14
-
-
0024542243
-
Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer
-
Ludwig Breast Cancer Study Group
-
Ludwig Breast Cancer Study Group. Prolonged disease-free survival after one course of perioperative adjuvant chemotherapy for node-negative breast cancer. N Engl J Med 320 (1989) 491-496
-
(1989)
N Engl J Med
, vol.320
, pp. 491-496
-
-
-
15
-
-
0035503794
-
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
-
Colleoni M., Gelber S., Coates A., et al. Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer. J Clin Oncol 19 (2001) 4141-4149
-
(2001)
J Clin Oncol
, vol.19
, pp. 4141-4149
-
-
Colleoni, M.1
Gelber, S.2
Coates, A.3
-
16
-
-
0032576360
-
Subsets within the chemotherapy overview
-
Coates A., Gelber R., and Goldhirsch A. Subsets within the chemotherapy overview. Lancet 352 (1998) 1783-1784
-
(1998)
Lancet
, vol.352
, pp. 1783-1784
-
-
Coates, A.1
Gelber, R.2
Goldhirsch, A.3
-
17
-
-
0003437040
-
-
Early Breast Cancer Trialists' Collaborative Group, Oxford University Press, Oxford, UK (accessed on Oct 8, 2007).
-
Early Breast Cancer Trialists' Collaborative Group. Treatment of Early Breast Cancer. Volume 1: Worldwide Evidence 1985-1990 (1990), Oxford University Press, Oxford, UK. Statistical methods also available at http://www.ctsu.ox.ac.uk/reports/ebctcg-1990/index_html (accessed on Oct 8, 2007).
-
(1990)
Treatment of Early Breast Cancer. Volume 1: Worldwide Evidence 1985-1990
-
-
|